José María Aguado Selected Research

Organ Transplantation

8/2022	Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
4/2022	Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression.
1/2022	Human genetic polymorphisms and risk of viral infection after solid organ transplantation.
12/2021	Reactivation of latent infections in solid organ transplant recipients from sub-Saharan Africa: What should be remembered?
4/2021	Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
1/2021	Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015.
1/2021	Prevention and therapy of viral infections in patients with solid organ transplantation.
10/2020	Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases.
1/2020	A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score.
1/2020	Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José María Aguado Research Topics

Disease

57	Infections 08/2022 - 02/2002
20	COVID-19 06/2022 - 01/2020
13	Sepsis (Septicemia) 08/2022 - 12/2012
10	Pneumonia (Pneumonitis) 06/2022 - 05/2005
8	Bacteremia 10/2021 - 06/2007
7	Urinary Tract Infections (Urinary Tract Infection) 10/2022 - 02/2018
6	Bacterial Infections (Bacterial Infection) 10/2022 - 06/2007
6	Neoplasms (Cancer) 03/2022 - 02/2002
6	Aspergillosis 01/2021 - 08/2003
6	Tuberculosis (Tuberculoses) 07/2019 - 06/2007
5	Communicable Diseases (Infectious Diseases) 08/2022 - 08/2005
5	Viremia 01/2022 - 12/2011
5	Virus Diseases (Viral Diseases) 01/2022 - 01/2008
5	Cytomegalovirus Infections (Inclusion Disease) 01/2018 - 12/2011
4	Invasive Candidiasis 05/2022 - 05/2011
4	Leishmaniasis 01/2022 - 08/2010
4	Septic Shock (Toxic Shock Syndrome) 01/2022 - 05/2014
4	Candidemia 12/2019 - 06/2012
3	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2006
3	Human Influenza (Influenza) 04/2021 - 01/2006
3	Diabetes Mellitus 04/2021 - 02/2002
3	Invasive Fungal Infections 04/2021 - 08/2003
3	Chronic Obstructive Pulmonary Disease (COPD) 04/2021 - 05/2005
3	Cytokine Release Syndrome 04/2021 - 01/2020
3	Bacteriuria 02/2021 - 03/2011
3	Neutropenia 01/2021 - 09/2012
3	Lymphopenia (Lymphocytopenia) 01/2021 - 06/2010
3	Mycoses (Diseases, Fungus) 01/2019 - 03/2016
3	Opportunistic Infections (Opportunistic Infection) 12/2018 - 02/2002
3	Renal Insufficiency (Renal Failure) 10/2018 - 02/2002
2	Cystitis 10/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2021 - 01/2018
2	Rheumatoid Arthritis 01/2021 - 01/2018
2	Latent Tuberculosis 01/2021 - 10/2009
2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Clostridium Infections 06/2019 - 08/2015
2	Iron Overload 02/2018 - 10/2013
2	Proteinuria 01/2018 - 03/2011
2	Endocarditis 01/2017 - 02/2009
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2017 - 08/2015
2	Mucormycosis 10/2013 - 02/2002
2	Intraabdominal Infections 09/2010 - 06/2007
2	Fever (Fevers) 05/2010 - 01/2006

Drug/Important Bio-Agent (IBA)

10	tocilizumab (atlizumab)FDA Link 06/2022 - 01/2020
10	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 04/2005
7	Vancomycin FDA LinkGeneric 10/2022 - 09/2015
6	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2017
6	CytokinesIBA 01/2022 - 12/2018
5	Biological ProductsIBA 01/2022 - 10/2018
5	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 05/2009
5	Pharmaceutical PreparationsIBA 08/2021 - 08/2003
5	EchinocandinsIBA 03/2020 - 05/2014
5	Methicillin (Metin)FDA Link 11/2018 - 02/2009
4	Fluconazole (Zonal)FDA LinkGeneric 05/2022 - 08/2003
4	Ganciclovir (Cytovene)FDA LinkGeneric 08/2021 - 01/2004
4	Voriconazole (Vfend)FDA LinkGeneric 10/2018 - 08/2003
3	Meropenem (Merrem)FDA LinkGeneric 10/2022 - 09/2010
3	Carbapenems (Carbapenem Antibiotics)IBA 08/2022 - 09/2010
3	AntigensIBA 03/2022 - 12/2021
3	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2015
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 09/2021
3	Valganciclovir FDA Link 08/2021 - 01/2008
3	C-Reactive ProteinIBA 06/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2021 - 08/2015
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 05/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2015
3	FluoroquinolonesIBA 07/2019 - 05/2005
3	VaccinesIBA 01/2018 - 07/2010
2	carbapenemaseIBA 06/2022 - 12/2019
2	Micafungin (FK463)FDA Link 05/2022 - 03/2020
2	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2022
2	InterleukinsIBA 01/2022 - 01/2020
2	InterferonsIBA 01/2022 - 01/2021
2	SteroidsIBA 10/2021 - 10/2009
2	beta-Lactamases (beta-Lactamase)IBA 10/2021 - 06/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2021 - 01/2021
2	AzolesIBA 04/2021 - 03/2020
2	Methylprednisolone FDA LinkGeneric 04/2021 - 02/2002
2	Fosfomycin FDA Link 02/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 02/2002
2	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2019 - 08/2003
2	Immunosuppressive Agents (Immunosuppressants)IBA 07/2019 - 10/2018
2	polyglucosanIBA 01/2018 - 01/2018

Therapy/Procedure

35	Therapeutics 06/2022 - 01/2004
23	Transplantation 08/2022 - 02/2002
20	Kidney Transplantation 11/2022 - 02/2002
19	Organ Transplantation 08/2022 - 02/2002
10	Catheters 06/2022 - 02/2009
8	Liver Transplantation 01/2021 - 02/2002
5	Immunomodulation 06/2022 - 01/2020
5	Duration of Therapy 08/2021 - 05/2009
3	Biological Therapy 01/2022 - 10/2018
3	Critical Care (Surgical Intensive Care) 09/2021 - 05/2011
2	Salvage Therapy 04/2021 - 02/2021
2	Drug Therapy (Chemotherapy) 11/2020 - 06/2010
2	Central Venous Catheters 10/2020 - 05/2014
2	Vascular Access Devices (Arterial Line) 08/2017 - 01/2014
2	Renal Dialysis (Hemodialysis) 10/2016 - 11/2009
2	Laparotomy 10/2016 - 02/2002
2	Secondary Prevention 10/2016 - 02/2015